AAAAAA

   
Results: 1-14 |
Results: 14
1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes - New biological responsemodifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties
Authors: Schertl, S Hartmann, RW Batzl-Hartmann, C Schlemmer, R Spruss, T Bernhardt, G Gust, R Schonenberger, H
Citation: S. Schertl et al., 1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes - New biological responsemodifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties, ARCH PHARM, 334(4), 2001, pp. 125-137
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound
Authors: Schlemmer, R Spruss, T Bernhardt, G Schonenberger, H
Citation: R. Schlemmer et al., Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound, ARCH PHARM, 334(10), 2001, pp. 309-317
Programmable biodegradable implants
Authors: Vogelhuber, W Rotunno, P Magni, E Gazzaniga, A Spruss, T Bernhardt, G Buschauer, A Gopferich, A
Citation: W. Vogelhuber et al., Programmable biodegradable implants, J CONTR REL, 73(1), 2001, pp. 75-88
"Hit-and-run" transformation by adenovirus oncogenes
Authors: Nevels, M Tauber, B Spruss, T Wolf, H Dobner, T
Citation: M. Nevels et al., "Hit-and-run" transformation by adenovirus oncogenes, J VIROLOGY, 75(7), 2001, pp. 3089-3094
Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice
Authors: Orso, E Broccardo, C Kaminski, WE Bottcher, A Liebisch, G Drobnik, W Gotz, A Chambenoit, O Diederich, W Langmann, T Spruss, T Luciani, MF Rothe, G Lackner, KJ Chimini, G Schmitz, G
Citation: E. Orso et al., Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice, NAT GENET, 24(2), 2000, pp. 192-196
Establishment and characterization of the follicular thyroid carcinoma cell line ML-1
Authors: Schonberger, J Bauer, J Spruss, T Weber, G Chahoud, I Eilles, C Grimm, D
Citation: J. Schonberger et al., Establishment and characterization of the follicular thyroid carcinoma cell line ML-1, J MOL MED-J, 78(2), 2000, pp. 102-110
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl) ethylenediamine]dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [Meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) inhibits this process
Authors: Schlemmer, R Spruss, T Bernhardt, G Schonenberger, H
Citation: R. Schlemmer et al., Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl) ethylenediamine]dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [Meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) inhibits this process, ARCH PHARM, 333(2-3), 2000, pp. 69-71
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice
Authors: Schlemmer, R Spruss, T Bernhardt, G Schonenberger, H
Citation: R. Schlemmer et al., Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice, ARCH PHARM, 333(12), 2000, pp. 397-403
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes inB6D2F(1) mice
Authors: Schlemmer, R Spruss, T Bernhardt, G Schonenberger, H
Citation: R. Schlemmer et al., Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes inB6D2F(1) mice, ARCH PHARM, 333(12), 2000, pp. 404-414
Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orfb protein
Authors: Nevels, M Rubenwolf, S Spruss, T Wolf, H Dobner, T
Citation: M. Nevels et al., Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orfb protein, J VIROLOGY, 74(11), 2000, pp. 5168-5181
The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53
Authors: Nevels, M Spruss, T Wolf, H Dobner, T
Citation: M. Nevels et al., The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53, ONCOGENE, 18(1), 1999, pp. 9-17
[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]sulfatoplatinum(II) - Pharmacokinetic studies
Authors: Bernhardt, G Koch, M Spruss, T Gust, R Krauser, R Schlemmer, R Hollstein, M Lux, F Schonenberger, H
Citation: G. Bernhardt et al., [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]sulfatoplatinum(II) - Pharmacokinetic studies, ARCH PHARM, 332(6), 1999, pp. 195-200
[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a compound with a specific activity on hormone-sensitive breast cancers - Evidence for a diethylstilbestrol-like mode of action
Authors: Schlemmer, R Spruss, T Bernhardt, G Schonenberger, H
Citation: R. Schlemmer et al., [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a compound with a specific activity on hormone-sensitive breast cancers - Evidence for a diethylstilbestrol-like mode of action, ARCH PHARM, 332(2), 1999, pp. 59-69
Transforming potential of the adenovirus type 5 E4orf3 protein
Authors: Nevels, M Tauber, B Kremmer, E Spruss, T Wolf, H Dobner, T
Citation: M. Nevels et al., Transforming potential of the adenovirus type 5 E4orf3 protein, J VIROLOGY, 73(2), 1999, pp. 1591-1600
Risultati: 1-14 |